US Consumers Face Inflation Pressure as Holiday Weekend Spending Surges on Travel Recreation and Food Costs Why Couples May Reconsider Paying Off a LowInterest Mortgage Despite Having Cash Paul Tudor Jones Says Theres No Chance Warsh Will Steer Fed Toward Rate Cuts Geopolitical Tensions Rise as Putin Vows Retaliation After Alleged Ukrainian Strike on Military Target Mortgage Rates Decline Across the Board on May 23 2026 30Year Fixed Drops to 634 Marvell United Airlines and Zscaler Lead Market Movers as Investors Assess Sector Trends TSM Q1 2026 Earnings EPS Crushes Estimates as AI Demand Fuels Record Profitability Mediaco Holding Inc MDIA Q3 2023 Earnings Net Loss Reported Amid Challenging Advertising Environment BKR Q1 2026 Earnings Strong EPS Beat of 1616 Driven by Operational Efficiency TOON Q3 2018 Earnings WiderThanExpected Loss Despite Stock Rally BBGI Q4 2025 Earnings Deep Loss of 695 Per Share Stock Gains 331 GRRR Q4 2025 Earnings Significant EPS Miss but Stock Rises Over 12 Sky Harbour Group SKYH Shows Modest Gains as Stock Tests Key Resistance Level Pebblebrook Hotel Trust PEB Holds Steady Near Support Whats Driving the Flat Trading Calisa Acquisition Corp Right ALISR Holds Steady at 056 Amid Low Volume Consolidation KKR Income Opportunities Fund KIO Edges Higher as YieldSeekers Maintain Interest ALX Oncology Holdings ALXO Holds Steady Near Support as Biotech Sector Watches Catalyst Calendar IHI Achieves Key Milestone with First Images from Observation Satellites OKTA Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Fulton Financial Preferred Shares FULTP Edge Lower Amid Modest Pullback DTW Q1 2026 Earnings EPS Misses Estimates as Debenture Price Slips ORKT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines SIM Q1 2023 Earnings Significant EPS Miss Amid Uncertainty HDB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher XTKG Q4 2019 Earnings Massive EPS Miss Triggers 43 Stock Plunge Citius Oncology Q1 2026 Earnings Wide EPS Miss Highlights PreRevenue Challenges INMB Q4 2025 Earnings Narrowing Losses Amid Clinical Pipeline Progress